Carotenoid intakes and risk of breast cancer defined by estrogen receptor and progesterone receptor status: a pooled analysis of 18 prospective cohort studies
- PMID: 22277553
- PMCID: PMC3278246
- DOI: 10.3945/ajcn.111.014415
Carotenoid intakes and risk of breast cancer defined by estrogen receptor and progesterone receptor status: a pooled analysis of 18 prospective cohort studies
Abstract
Background: Epidemiologic studies examining associations between carotenoid intakes and risk of breast cancer by estrogen receptor (ER) and progesterone receptor (PR) status are limited.
Objective: We investigated these associations in a pooled analysis of 18 cohort studies.
Design: Of 1,028,438 participants followed for a maximum follow-up of 26 y across studies, 33,380 incident invasive breast cancers were identified. Study-specific RRs and 95% CIs were estimated by using Cox proportional hazards regression and then pooled by using a random-effects model.
Results: α-Carotene, β-carotene, and lutein/zeaxanthin intakes were inversely associated with the risk of ER-negative (ER-) breast cancer (pooled multivariable RRs of the comparison between the highest and lowest quintiles): α-carotene (0.87; 95% CI: 0.78, 0.97), β-carotene (0.84; 95% CI: 0.77, 0.93), and lutein/zeaxanthin (0.87; 95% CI: 0.79, 0.95). These variables were not inversely associated with the risk of ER-positive (ER+) breast cancer (pooled multivariable RRs for the same comparison): α-carotene (1.04; 95% CI: 0.99, 1.09), β-carotene (1.04; 95% CI: 0.98, 1.10), and lutein/zeaxanthin (1.00; 95% CI: 0.93, 1.07). Although the pooled RRs for quintile 5 for β-cryptoxanthin were not significant, inverse trends were observed for ER- and ER+ breast cancer (P-trend ≤ 0.05). Nonsignificant associations were observed for lycopene intake. The associations were largely not appreciably modified by several breast cancer risk factors. Nonsignificant associations were observed for PR-positive and PR-negative breast cancer.
Conclusions: Intakes of α-carotene, β-carotene, and lutein/zeaxanthin were inversely associated with risk of ER-, but not ER+, breast cancer. However, the results need to be interpreted with caution because it is unclear whether the observed association is real or due to other constituents in the same food sources.
Similar articles
-
Circulating carotenoids and risk of breast cancer: pooled analysis of eight prospective studies.J Natl Cancer Inst. 2012 Dec 19;104(24):1905-16. doi: 10.1093/jnci/djs461. Epub 2012 Dec 6. J Natl Cancer Inst. 2012. PMID: 23221879 Free PMC article.
-
Reinterpretation of the results of a pooled analysis of dietary carotenoid intake and breast cancer risk by using the interval collapsing method.Epidemiol Health. 2016 Jun 2;38:e2016024. doi: 10.4178/epih.e2016024. eCollection 2016. Epidemiol Health. 2016. PMID: 27283141 Free PMC article.
-
Selected antioxidants and risk of hormone receptor-defined invasive breast cancers among postmenopausal women in the Women's Health Initiative Observational Study.Am J Clin Nutr. 2008 Apr;87(4):1009-18. doi: 10.1093/ajcn/87.4.1009. Am J Clin Nutr. 2008. PMID: 18400726 Free PMC article.
-
Carotenoid Intake and Circulating Carotenoids Are Inversely Associated with the Risk of Bladder Cancer: A Dose-Response Meta-analysis.Adv Nutr. 2020 May 1;11(3):630-643. doi: 10.1093/advances/nmz120. Adv Nutr. 2020. PMID: 31800007 Free PMC article.
-
Dietary Intake and Circulating Concentrations of Carotenoids and Risk of Type 2 Diabetes: A Dose-Response Meta-Analysis of Prospective Observational Studies.Adv Nutr. 2021 Oct 1;12(5):1723-1733. doi: 10.1093/advances/nmab048. Adv Nutr. 2021. PMID: 33979433 Free PMC article.
Cited by
-
Carotenoid Lutein Selectively Inhibits Breast Cancer Cell Growth and Potentiates the Effect of Chemotherapeutic Agents through ROS-Mediated Mechanisms.Molecules. 2018 Apr 14;23(4):905. doi: 10.3390/molecules23040905. Molecules. 2018. PMID: 29662002 Free PMC article.
-
Healthful and Unhealthful Plant-Based Diets and Risk of Breast Cancer in U.S. Women: Results from the Nurses' Health Studies.Cancer Epidemiol Biomarkers Prev. 2021 Oct;30(10):1921-1931. doi: 10.1158/1055-9965.EPI-21-0352. Epub 2021 Jul 21. Cancer Epidemiol Biomarkers Prev. 2021. PMID: 34289970 Free PMC article.
-
Body size and weight change over adulthood and risk of breast cancer by menopausal and hormone receptor status: a pooled analysis of 20 prospective cohort studies.Eur J Epidemiol. 2021 Jan;36(1):37-55. doi: 10.1007/s10654-020-00688-3. Epub 2020 Oct 30. Eur J Epidemiol. 2021. PMID: 33128203 Free PMC article.
-
Dietary inflammatory potential, oxidative balance score, and risk of breast cancer: Findings from the Sister Study.Int J Cancer. 2021 Aug 1;149(3):615-626. doi: 10.1002/ijc.33581. Epub 2021 Apr 27. Int J Cancer. 2021. PMID: 33783833 Free PMC article.
-
Premenopausal plasma carotenoids, fluorescent oxidation products, and subsequent breast cancer risk in the nurses' health studies.Breast Cancer Res Treat. 2015 Jun;151(2):415-25. doi: 10.1007/s10549-015-3391-6. Epub 2015 Apr 28. Breast Cancer Res Treat. 2015. PMID: 25917867 Free PMC article.
References
-
- Mangels AR, Holden JM, Beecher GR, Forman MR, Lanza E. Carotenoid content of fruits and vegetables: an evaluation of analytic data. J Am Diet Assoc 1993;93:284–96 - PubMed
-
- Peto R, Doll R, Buckley JD, Sporn MB. Can dietary beta-carotene materially reduce human cancer rates? Nature 1981;290:201–8 - PubMed
-
- Steinmetz KA, Potter JD. Vegetables, fruit, and cancer. II. Mechanisms. Cancer Causes Control 1991;2:427–42 - PubMed
-
- Rao AV, Rao LG. Carotenoids and human health. Pharmacol Res 2007;55:207–16 - PubMed
-
- Frei B. Reactive oxygen species and antioxidant vitamins: mechanisms of action. Am J Med 1994;97(3A):5S–13S; discussion 22S–8S - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials